J
9877
vs
H
Hang Seng (Hong Kong)
Over the past 12 months, Jenscare Scientific Co Ltd has significantly outperformed Hang Seng (Hong Kong), delivering a return of +95% compared to the Hang Seng (Hong Kong)'s +16% growth.
Stocks Performance
9877 vs Hang Seng (Hong Kong)
Performance Gap
9877 vs Hang Seng (Hong Kong)
Performance By Year
9877 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jenscare Scientific Co Ltd
Glance View
Jenscare Scientific Co., Ltd. is a holding company, which engages in the development and sale of transcatheter aortic valve systems. The company is headquartered in Ningbo, Zhejiang. The company went IPO on 2022-10-10. The firm develops interventional products for the treatment of structural heart disease. The firm's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The firm also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. The firm mainly conducts its businesses in the domestic market.
